Logo image of OMEX

ODYSSEY MARINE EXPLORATION (OMEX) Stock Fundamental Analysis

USA - NASDAQ:OMEX - US6761182012 - Common Stock

2.92 USD
+0.26 (+9.77%)
Last: 10/7/2025, 8:00:02 PM
2.92 USD
0 (0%)
Pre-Market: 10/8/2025, 4:12:47 AM
Fundamental Rating

1

Overall OMEX gets a fundamental rating of 1 out of 10. We evaluated OMEX against 84 industry peers in the Commercial Services & Supplies industry. Both the profitability and financial health of OMEX have multiple concerns. OMEX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

OMEX had positive earnings in the past year.
In the past year OMEX has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: OMEX reported negative net income in multiple years.
In the past 5 years OMEX reported 4 times negative operating cash flow.
OMEX Yearly Net Income VS EBIT VS OCF VS FCFOMEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

The Return On Assets of OMEX (6.52%) is better than 78.57% of its industry peers.
Industry RankSector Rank
ROA 6.52%
ROE N/A
ROIC N/A
ROA(3y)-22.03%
ROA(5y)-60.76%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OMEX Yearly ROA, ROE, ROICOMEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200

1.3 Margins

OMEX has a Profit Margin of 174.26%. This is amongst the best in the industry. OMEX outperforms 100.00% of its industry peers.
The Operating Margin and Gross Margin are not available for OMEX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 174.26%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OMEX Yearly Profit, Operating, Gross MarginsOMEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K 2K

More info and screens

0

2. Health

2.1 Basic Checks

OMEX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OMEX has been increased compared to 1 year ago.
OMEX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, OMEX has a worse debt to assets ratio.
OMEX Yearly Shares OutstandingOMEX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
OMEX Yearly Total Debt VS Total AssetsOMEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -27.63, we must say that OMEX is in the distress zone and has some risk of bankruptcy.
OMEX has a worse Altman-Z score (-27.63) than 94.05% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -27.63
ROIC/WACCN/A
WACC7.77%
OMEX Yearly LT Debt VS Equity VS FCFOMEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M -30M

2.3 Liquidity

OMEX has a Current Ratio of 0.13. This is a bad value and indicates that OMEX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of OMEX (0.13) is worse than 95.24% of its industry peers.
OMEX has a Quick Ratio of 0.13. This is a bad value and indicates that OMEX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.13, OMEX is doing worse than 95.24% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.13
Quick Ratio 0.13
OMEX Yearly Current Assets VS Current LiabilitesOMEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

1

3. Growth

3.1 Past

OMEX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 107.68%, which is quite impressive.
The Revenue has decreased by -4.37% in the past year.
Measured over the past years, OMEX shows a very negative growth in Revenue. The Revenue has been decreasing by -24.19% on average per year.
EPS 1Y (TTM)107.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-547.32%
Revenue 1Y (TTM)-4.37%
Revenue growth 3Y-5.81%
Revenue growth 5Y-24.19%
Sales Q2Q%-37.38%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OMEX Yearly Revenue VS EstimatesOMEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
OMEX Yearly EPS VS EstimatesOMEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2022 2023 -1 -2 -3 -4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 32.44 indicates a quite expensive valuation of OMEX.
OMEX's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of OMEX to the average of the S&P500 Index (27.76), we can say OMEX is valued inline with the index average.
Industry RankSector Rank
PE 32.44
Fwd PE N/A
OMEX Price Earnings VS Forward Price EarningsOMEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OMEX Per share dataOMEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

OMEX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ODYSSEY MARINE EXPLORATION

NASDAQ:OMEX (10/7/2025, 8:00:02 PM)

Premarket: 2.92 0 (0%)

2.92

+0.26 (+9.77%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)08-08 2025-08-08
Earnings (Next)11-11 2025-11-11
Inst Owners18.26%
Inst Owner Change0%
Ins Owners4.43%
Ins Owner Change20.72%
Market Cap139.05M
Analysts82.86
Price TargetN/A
Short Float %11.19%
Short Ratio1.79
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 32.44
Fwd PE N/A
P/S 224.24
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.09
EY3.08%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.15
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS0.01
BVpS-1.11
TBVpS-1.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.52%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 174.26%
GM N/A
FCFM N/A
ROA(3y)-22.03%
ROA(5y)-60.76%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.13
Quick Ratio 0.13
Altman-Z -27.63
F-Score2
WACC7.77%
ROIC/WACCN/A
Cap/Depr(3y)620.57%
Cap/Depr(5y)412.34%
Cap/Sales(3y)93.35%
Cap/Sales(5y)56.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)107.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-547.32%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.37%
Revenue growth 3Y-5.81%
Revenue growth 5Y-24.19%
Sales Q2Q%-37.38%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-16.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y51.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y47.68%
OCF growth 3YN/A
OCF growth 5YN/A